Bevatas 400 (Bevacizumab Vials) 400mg/16ml

Bevatas 400 is a bevacizumab formulation in 400mg/16ml vials, manufactured by Intas Pharmaceuticals. Used as a targeted therapy in oncology, it helps manage certain cancers by inhibiting blood vessel growth. Store between 2-8°C to maintain potency. Ideal for clinical settings requiring precise dosing.

Strength

400mg/16ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Intas Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bevatas 400 is used in cancer treatment to slow tumor growth by blocking vascular endothelial growth factor (VEGF). It is commonly prescribed for metastatic colorectal cancer, non-small cell lung cancer, and other solid tumors. Patients often ask, what is bevacizumab used for, and this medication supports therapy when combined with other treatments. It is administered under medical supervision in clinical environments.

Side Effects

Bevatas 400 works by reducing blood supply to tumors, which may help shrink or slow their progression. Common effects include fatigue, high blood pressure, and changes in blood counts. Some patients experience mild nausea or headaches during treatment. These effects vary based on individual health conditions and concurrent therapies.

Precautions & Warnings

Store Bevatas 400 vials refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the vial. Use aseptic technique during preparation to prevent contamination. Discard any unused portion after opening, as it contains no preservatives. Keep out of reach of children and pets.

Avoid Interactions

Bevatas 400 may interact with other medications affecting blood pressure or blood clotting. Combining it with certain chemotherapy drugs or anticoagulants could increase side effects. Avoid alcohol during treatment, as it may worsen fatigue or nausea. Always inform your healthcare provider about all medications being taken.

References

Frequently Asked Questions

Bevatas 400 is used to treat certain cancers by slowing tumor growth through blood vessel inhibition.

Store vials refrigerated between 2-8°C and protect from light; do not freeze or shake.

Administration should be supervised by a healthcare professional in a clinical setting.

Common effects include fatigue, high blood pressure, and changes in blood counts.

It may interact with drugs affecting blood pressure, clotting, or chemotherapy agents.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.